Life Sciences
4 articles
Single-Cell CRISPR Assays Market Poised to Surpass $1 Billion by 2028
Researchers can now pinpoint how individual cells respond to gene edits, a capability previously impossible with bulk sequencing, unlocking a new era of precision medicine, according to Cell Journal .
Life Sciences Must Build A Business Case For Health Outcomes
Over 20% of all U.S. prescriptions are never filled. For high-cost therapies, this problem intensifies: 60% of prescriptions costing $500 or more out-of-pocket are abandoned, according to Healthcare I
DayOne Accelerator Program for Healthtech Startups Launches Applications
The DayOne Accelerator Program is now accepting applications for its three-month hybrid program in Basel, Switzerland, targeting early-stage healthtech and techbio ventures. This equity-free opportunity offers financial support and potential follow-on funding.
China's Cryopreservation Media Market: Analyzing Growth Drivers Through 2035
The foundational components of China's bio-preservation infrastructure are signaling a decade of sustained expansion, creating new strategic imperatives for companies in the life sciences sector.